InvestorsHub Logo
Followers 58
Posts 10221
Boards Moderated 1
Alias Born 09/21/2016

Re: Biostockclub post# 249892

Saturday, 05/09/2020 9:28:50 AM

Saturday, May 09, 2020 9:28:50 AM

Post# of 465859
Totally agree w/you on links to Oncology (PM) and the thinking presented by AVXL, Particularly after the recent HH AI paper and our "Consortium" . Lots of dots out there these days.

This third paragraph is in parallel to what we are doing.
“Lilly's drug is part of a trend of treating cancer based on a patient's genetics rather than the location in the body where the disease originated.”

So, if we can see in print, “Lilly’s drug approved for treating 3 types of tumors”,
we should not be surprised to read some day that “Anavex’s drug approved for treating 3 types of CNS diseases.”

FDA approves Eli Lilly drug to treat three types of tumors https://seekingalpha.com/news/3572368

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News